Chinese medicine treatment for non-small cell lung cancer enters clinical research stage

The National Eleventh Five-Year Science and Technology Support Program “Research on Comprehensive Treatment Program for Non-small Cell Lung Cancer Chinese Medicine” is currently actively conducting multi-center clinical research. This topic is a subject approved by the Ministry of Science and Technology and the State Administration of Traditional Chinese Medicine. Professor Lin Hongsheng and Prof. Hua Baojin of the Oncology Department of Guang'anmen Hospital of the Academy of Sciences are responsible for the implementation of a number of clinical research institutions across the country, aiming to form a comprehensive Chinese medicine treatment plan for non-small cell lung cancer with proven evidence, available for promotion and wide recognition.

According to reports, non-small cell lung cancer accounts for about 80% of lung cancer incidence. The comprehensive treatment plan for Chinese medicine is an important part of the treatment of lung cancer in China. Therefore, the establishment of TCM treatment norms and clinical practice guidelines for non-small cell lung cancer is extremely urgent. Previous research results have confirmed that Chinese medicine combined with radiotherapy and chemotherapy can increase efficiency and reduce toxicity. Postoperative Chinese medicine intervention can delay tumor recurrence and metastasis and prolong survival time.

It is reported that the subject is approved by the Ministry of Science and Technology and the State Administration of Traditional Chinese Medicine*, and it has also cooperated fully with Columbia University and the National Cancer Institute.

Curing Agent For Epoxy Resin

Curing Agent For Epoxy Resin,High Grade Epoxy Resin Curing Agent,Liquid Epoxy Resin Curing Agent,

Ningxia Darong Chemicals & Metallurgy Co., Ltd. , https://www.darong-cyanamide.com